Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) Stock Short Interest Report for October

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) saw a significant decrease in short interest in the month of October. As of October 15th, there was short interest totaling 53 shares, a decrease of 89.9% from the September 30th total of 526 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 5,493 shares, the days-to-cover ratio is currently 0.0 days.

Orion OYJ Price Performance

ORINY opened at $55.85 on Tuesday. Orion OYJ has a fifty-two week low of $30.89 and a fifty-two week high of $55.85. The firm has a 50-day moving average of $46.92 and a 200 day moving average of $41.27. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.48 and a current ratio of 2.64. The firm has a market cap of $15.76 billion, a P/E ratio of 22.98 and a beta of 0.07.

Orion OYJ Company Profile

Orion Oyj, also known as Orion Corporation, is a Finnish pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its portfolio includes prescription medicines, over-the-counter products, generic pharmaceuticals and active pharmaceutical ingredients.

The company focuses on several therapeutic areas, including central nervous system disorders, oncology, respiratory diseases, pain management and veterinary medicine. Orion is particularly recognized for treatments related to Parkinson’s disease, as well as its Easyhaler line of inhaled medicines for respiratory conditions.

Founded in Finland in 1917, Orion is headquartered in Espoo.